Supplementary Figure 2

Oct 23, 2014

10 likes | 122 Views

Supplementary Figure 2. Week 1. Week 2. Indicator Cells GFP MFI.

Share Presentation

Embed Code

Link

week 2
week 1
supplementary figure 2
indicator cells gfp mfi

garin

Download Presentation

Supplementary Figure 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Supplementary Figure 2 Week 1 Week 2 Indicator Cells GFP MFI

Supplementary figure 2

Supplementary figure 2. +/+ +/m. kb. 12. 8. M +/+ +/m m/m. 2 kb 540bp 387bp. a. b. c. d. Supplementary figure 2. Generation of Unc5b mutant mice

243 views • 2 slides

Supplementary Figure 2.

RCA. RVN. LCA. LVN. LCA. RVN. RJV. T. RJV. T. LVN. LJV. ARSA. E. LJV. TR. E. LSA. ARSA. TR. LSA. RCA. RSV. LSV. RSV. LSV. LBV. LBV. RL. LL. RL. LL. TD. H. H. Supplementary Figure 2.

86 views • 1 slides

Supplementary figure 2

Supplementary figure 2 PCA analysis of all the different cell lines used in the microarray experiments revealing three distinct sub groups ; translocation positive RMS cells (RMS, RMZ, RH3, RH40, RH41), translocation negative RMS cells (RD & RH18)and myoblasts (MYO & BIO).

149 views • 1 slides

Supplementary Figure 2

cd73 -/- +DSS Day 10. cd73 -/- + DSS Day 22. WT +DSS Day 10. WT +DSS Day 22. NF-  appaB p65 kDa. Supplementary Figure 2.

93 views • 1 slides

Supplementary Figure 2

Sigmoidal Fits, E02 Retinotopy. All fits have adjR 2 >0.95. 1.0. 1.0. 0.9. 0.9. 0.8. 0.8. 0.7. 0.7. 0.6. 0.6. 0.5. 0.5. 0.4. 0.4. 0.3. Normal Cortex. LPZ Center. 0.3. 0.2. 0.2. 0.1. 4. 4. 6. 6. 2. 2. -4. -4. -2. -2. 0. 0. -6. -6. 0 14 28 42

85 views • 1 slides

Supplementary Figure 2

Mt. Esja. Pop. 15. Pop. 14. Mt. Esja. Mt. Esja. Mt. Esja. Mt. Esja. Mt. Esja. Mt. Esja. Mt. Esja. Mt. Esja. Pop. 2. Pop. 1. Pop. 2. Pop. 2. Mt. Esja. S unknown. Mt. Esja. 100. Mt. Esja. S12. 74. Pop. 6. Pop. 2. Pop. 2. S16. Mt. Esja. S16. Pop.5. 98. Pop. 6.

113 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2. %. 15. 10. Vβ. 5. 0. 2. 4. 8. 10. 12. 14. 16. 18. 7. 1. 3. 5a. 6. 9. 11. 13. 15. 17. 19. 20. 5b. 15. 10. Vα. 5. 0. 2. 6. 8. 10. 12. 14. 16. 17. 1. 3. 4a. 4b. 5. 7. 9. 11. 13. 15. 18. 21. 24.

65 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2. A B. PSA-Cre + /Pten +/+ PSA-Cre + /Pten loxP/loxP. Age ( wks ). 20 20 30 80. Weeks.

141 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2. 14 days in culture. 21 days in culture. A. B. A. B. C. D. C. D. E. SF2.

75 views • 1 slides

Supplementary Figure 2

ND. ob/ob. Supplementary Figure 2. A. IL6. TNF α. IL1 β. IL10. CXCL10. CCL5. CCL2. IL6. TNF α. IL1 β. IL10. CXCL10. CCL5. CCL2. 12000. 2250. 12000. 150. 500. 5000. 15000. 35000. 2000. 10000. 10000. 120. 1750. 30000. 12500. 400. 4000. 8000. 1500. 8000. 25000.

115 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2. MDA-MB-231. MDA-MB-231 HM.

94 views • 1 slides

Supplementary Figure 2

A. HEK293. MRC-5. SKOV-3. MDAH-2774. Igfbp5 mRNA. Gapdh mRNA. anti-IGFBP-5. anti- b -actin. B. mock. IGFBP-5. mock. IGFBP-5. 2000. 1500. anti-CD31 (PECAM-1). tumor volume (mm 2 ). 1000. *. 500. 0. mock. IGFBP-5. 20. 15. number of blood vessels per tumor section. 10.

152 views • 2 slides

Supplementary Figure 2

Supplementary Figure 2. PDPN + cells. A. 90.8%. CAF 4. 37.6%. PDPN - cells. 0.44%. low. PDPN. high. B.

120 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2. A. BWS. Number of Patients. 0 1 2 3 4 5 6 7 8 9 10 11 1213 1415 16 17 1819 20. death. 0 1 2 3 4 5 6 7 8 9 10 11 12 131415 1617 18 19 20 2122 23over. Years. B. AS. 25 20 15 10 5 0.

111 views • 2 slides

Supplementary Figure 2

A. *. B. *. *. *. Supplementary Figure 2.

65 views • 1 slides

Supplementary Figure 2

(a). (c). (b). (d). Supplementary Figure 2.

61 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2. Con. A. PELP1 Tg. Cyclin D1. B. Con. PELP1 Tg. Ser991 PELP1. Figure S2. Representative IHC images showing the status of cyclin D1 ( A ) and phos-PELP1 ( B )in the mammary glands of 6-month-old control and MMTV-rtTA-TetO-PELP1 bitransgenic mice.

221 views • 1 slides

Supplementary Figure 2

HCT116. HCT116. NT. SN. NT. SN38. 5. 1.6. LC3 labelling. 4. 1.2. SN38 IC50 (nM). 3. 0.8. LC3 spots/cell. LC3. 0.4. 2. HCT116. Actin. 0. 1. Clonogenic assay. SN38. siCT. siATG5. siATG7. 0. shLUC. shMAPK14. HCT116. NT. SN38. 3. LC3. Cytotoxic assay. 100. GAPDH.

109 views • 1 slides

Supplementary figure 2.

Supplementary figure 2. p = 0.018, Kolmogorov-Smirnov test p = 0.011, Chi squared test, Pearsons corrected.

62 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2.

65 views • 1 slides

More Related